Sarah Ketterer - Causeway Capital Management
Holding/activity history for Quest Diagnostics (DGX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | 0.43 | SEC | ||
| 2025 Q1 | 120,400 | 0.43 | Reduce 60.46% | 0.63 | $169.20 | $20,371,692 | SEC |
| 2024 Q4 | 304,481 | 1.05 | Reduce 10.99% | 0.14 | $150.86 | $45,934,011 | SEC |
| 2024 Q3 | 342,060 | 1.30 | Reduce 28.16% | 0.50 | $155.25 | $53,104,835 | SEC |
| 2024 Q2 | 476,116 | 1.78 | Reduce 4.99% | 0.09 | $136.88 | $65,170,798 | SEC |
| 2024 Q1 | 501,117 | 1.75 | Add 1.71% | 0.03 | $133.18 | $66,737,994 | SEC |
| 2023 Q4 | 492,707 | 1.73 | Add 0.62% | 0.01 | $137.88 | $67,934,466 | SEC |
| 2023 Q3 | 489,694 | 1.57 | Add 58.74% | 0.58 | $121.86 | $59,674,164 | SEC |
| 2023 Q2 | 308,493 | 1.14 | Buy | 1.14 | $140.56 | $43,361,828 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.83 | SEC | ||
| 2021 Q2 | 305,502 | 0.83 | Reduce 4.40% | 0.04 | $131.97 | $40,317,000 | SEC |
| 2021 Q1 | 319,572 | 0.81 | Buy | 0.81 | $128.34 | $41,014,000 | SEC |